Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.60 |
| ▸ | CPA3 | P15088 | 3/20 | 0.50 |
| ▸ | PPARG | P37231 | 2/20 | 0.49 |
| ▸ | CPA1 | P15085 | 2/20 | 0.49 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.49 |
| ▸ | CPB1 | P15086 | 1/20 | 0.49 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.49 |
| ▸ | MME | P08473 | 5/20 | 0.46 |
| ▸ | UBE2N | P61088 | 1/20 | 0.45 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.45 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.45 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.45 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.45 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.45 |
| ▸ | ACE | P12821 | 4/20 | 0.44 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.44 |
| ▸ | ANPEP | P15144 | 1/20 | 0.44 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.44 |
| ▸ | DNPEP | Q9ULA0 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1709339 | 0.85 | CYP1A2 (0.64) | CYP1A2CPA3PPARGCPA1FOLH1 | |
| SCHEMBL1709283 | 0.85 | CYP1A2 (0.64) | CYP1A2CPA3PPARGCPA1FOLH1 | |
| SCHEMBL2363354 | 0.84 | CYP1A2 (0.62) | CYP1A2CPA3PPARGCPA1FOLH1 | |
| SCHEMBL6897164 | 0.82 | CYP1A2 (0.60) | CYP1A2CPA3PPARGCPA1FOLH1 | |
| SCHEMBL4886609 | 0.81 | CYP1A2 (0.69) | CYP1A2CPA3PPARGCPA1FOLH1 | |
| SCHEMBL491524 | 0.81 | CYP1A2 (0.83) | CYP1A2CPA3PPARGCPA1FOLH1 | |
| SCHEMBL265514 | 0.81 | CYP1A2 (0.83) | CYP1A2CPA3PPARGCPA1FOLH1 | |
| SCHEMBL265063 | 0.81 | CYP1A2 (0.83) | CYP1A2CPA3PPARGCPA1FOLH1 | |
| SCHEMBL6121990 | 0.80 | CYP1A2 (0.47) | CYP1A2CPA3UBE2NSLC15A1TRPA1 | |
| SCHEMBL2565008 | 0.80 | CYP1A2 (0.52) | CYP1A2CPA3CPA1FOLH1CPB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 97 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12139627-B2 | Perovskite ink formulations | EXCYTON LIMITED (GB) | 2024-11-12 | — | — | US | claimed |
| EP-3809876-A1 | PROTECTIVE AGENT FOR FOOD PRODUCTS AND THE LIKE AND FOR CURING AND/OR STORAGE ROOMS OF THE SAME | PERPRIN S.R.L. (IT) | 2021-04-28 | — | — | EP | claimed |
| EP-3649183-A1 | SILICONE COMPOUNDS | The Procter and Gamble Company (US) | 2020-05-13 | — | — | EP | claimed |
| EP-3649184-A1 | SILICONE COMPOUNDS | The Procter and Gamble Company (US) | 2020-05-13 | — | — | EP | claimed |
| WO-2019243869-A1 | PROTECTIVE AGENT FOR FOOD PRODUCTS AND THE LIKE AND FOR CURING AND/OR STORAGE ROOMS OF THE SAME | PERPRIN S.R.L. (IT) | 2019-12-26 | — | — | WO | claimed |
| US-20190010427-A1 | SILICONE COMPOUNDS | THE PROCTER & GAMBLE COMPANY | 2019-01-10 | — | — | US | claimed |
| US-20190010293-A1 | SILICONE COMPOUNDS | THE PROCTER & GAMBLE COMPANY | 2019-01-10 | — | — | US | claimed |
| WO-2019010263-A1 | SILICONE COMPOUNDS | THE PROCTER & GAMBLE COMPANY (US) | 2019-01-10 | — | — | WO | claimed |
| WO-2019010265-A1 | SILICONE COMPOUNDS | THE PROCTER & GAMBLE COMPANY (US) | 2019-01-10 | — | — | WO | claimed |
| WO-2009131692-A1 | SUBSTRATES FOR DELIVERY OF PHYSIOLOGICALLY ACTIVE AGENTS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) | 2009-10-29 | — | — | WO | claimed |
| US-20260062692-A1 | COMPOSITIONS AND METHODS FOR THE IMMOBILIZATION OF ENZYMES USING CROSSLINKED BIOMOLECULAR CONDENSATES | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2026-03-05 | — | — | US | disclosed |
| EP-4644408-A1 | POLYETHYLENIMINE-MODIFIED CRY PROTEINS AND THEIR USE | The Chinese University of Hong Kong Office of Research and Knowledge Transfer Services (ORKTS) (HK) | 2025-11-05 | — | — | EP | disclosed |
| US-20250302014-A1 | WASP PEST MANAGEMENT SYSTEM | TONER DARADH (IE) | 2025-10-02 | — | — | US | disclosed |
| CN-120051204-A | Humanized immunodeficiency mouse model | 杰克逊实验室 | 2025-05-27 | — | — | CN | disclosed |
| EP-4518647-A1 | WASP PEST MANAGEMENT SYSTEM | Toner, Daradh (IE) | 2025-03-12 | — | — | EP | disclosed |
| WO-2009131692-A1 | SUBSTRATES FOR DELIVERY OF PHYSIOLOGICALLY ACTIVE AGENTS | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) | 2009-10-29 | — | — | WO | disclosed |
| US-7452555-B2 | Cocrystallization | S.S.C.I., INC. (US) | 2008-11-18 | — | — | US | disclosed |
| US-20070287194-A1 | Screening For Solid Forms By Ultrasound Crystallization And Cocrystallization Using Ultrasound | S.S.C.I., INC | 2007-12-13 | — | — | US | disclosed |
| US-20070088508-A1 | Cocrystallization methods | APTUIT (WEST LAFAYETTE), LLC | 2007-04-19 | — | — | US | disclosed |
| EP-0663897-B1 | PROCESS FOR SEPARATING ENANTIOMERS FROM A RACEMIC MIXTURE | AKZO NOBEL NV (NL) | 1997-01-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260062692-A1 | COMPOSITIONS AND METHODS FOR THE IMMOBILIZATION OF ENZYMES USING CROSSLINKED BIOMOLECULAR CONDENSATES | ADH5, ADH1C, ADH1A | CYP1A2 981/4885CPA3 1111/4885PPARG 1523/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.